No abstract available.
Gallbladder ; Gallbladder Neoplasms

No abstract available.
Gallbladder Neoplasms* ; Gallbladder*

13 patients with the gallbladder cancer diagnosed by ultrasound in which 6 patients received CT scanner, these images compared with the operational results and pathological anatomy. The gallbladder cancer occurred most frequently in the elderly and had the poor prognosis. The ultrasound showed the unfair thickness of gallbladder wall (66.7%) rough tumor from the posterior wall to gallbladder
Gallbladder Neoplasms ; Ultrasonography ; Diagnosis

No abstract available.
Gallbladder Neoplasms* ; Gallbladder* ; Humans ; Siblings* ; Umbilicus*

No abstract available.
Cholecystectomy, Laparoscopic* ; Gallbladder Neoplasms* ; Gallbladder* ; Reoperation*

No abstract available.
Gallbladder Neoplasms ; Gallbladder ; Liver Abscess ; Liver

Gallbladder Diseases ; Gallbladder Neoplasms ; Humans ; Polyps

PURPOSE: We evaluated the correlation between clinicopathologic features and p53, c-erbB-2 and Ki-67 protein expression in gallbladder carcinoma. METHODS: From Jan. 1994 to July 1999, thirty-four cases of gallbladder carcinoma were enrolled in this study and their clinicopathologic findings were analyzed. We performed p53, c-erbB-2, and Ki-67 immunohistochemical staining on formalin fixed, paraffin embedded histological sections with an antibody. RESULTS: The rate of overexpression of p53, c-erbB-2, and Ki-67 protein in gallbladder carcinoma was 47.1%, and 70.6%, 55.9%, respectively. The five year patient survival rate was significantly correlated only with tumor stage; the rate being 64.7% (P=0.031) with p53-negative tumors and 59.0% (P=0.023) with c-erbB-2-positive tumors. CONCLUSION: Progressively increasing incidence of p53, c-erbB-2 and Ki-67 protein overexpression was observed in gallbladder carcinoma patients. Although this study found no correlation between the molecular markers and survival, further study will be needed to evaluate the significance of p53, c-erbB-2 and Ki-67 proteins as prognostic factors.
Formaldehyde ; Gallbladder Neoplasms ; Gallbladder* ; Humans ; Incidence ; Paraffin ; Survival Rate

Primary gallbladder cancer is a highly malignant tumor and is characterized by early metastasis and rapid progression of disease. Since the majority of patients have unresectable disease, laparotomy, instead of providing relief of symptoms, often adds to the morbidity and needs to be avoided in patients with advanced disease. Clinical features, peritoneoscopic findings, and comparison of peritoneoscopy with radiologic studies were reviewed in 29 patients, who underwent peritoneoscopy, with primary gallbladder cancer at Severaace Hospital, College of Medicine, Yonsei University between Aug. 1982 and Mar. 1994. (continue...)
Gallbladder Neoplasms* ; Gallbladder* ; Humans ; Laparoscopy* ; Laparotomy ; Neoplasm Metastasis

PURPOSE: The purpose of this study is to assess the role of adjuvant therapy in stage I-III gallbladder cancer (GBC) patients who have undergone R0 resection. MATERIALS AND METHODS: Clinical data were collected on 441 consecutive patients who underwent R0 resection for stage I-III GBC. Eligible patients were classified into adjuvant therapy and surveillance only groups. Propensity score matching (PSM) between the two groups was performed, adjusting clinical factors. RESULTS: In total, 84 and 279 patients treated with adjuvant therapy and followed up with surveillance only, respectively, were included in the analysis. Before PSM, the 5-year relapse-free survival (RFS) rate was lower in the adjuvant therapy group than in the surveillance only group (50.8% vs. 74.8%, p < 0.001), although there was no statistically significant difference in the 5-year overall survival (OS) rate (66.2% vs. 79.5%, p=0.089). After the PSM, baseline characteristics became comparable and there were no differences in the 5-year RFS (50.8% vs. 64.8%, p=0.319) and OS (66.2% vs. 70.4%, p=0.703) rates between the two groups. CONCLUSION: The results suggest that fluoropyrimidine-based adjuvant therapy is not indicated in stage I-III GBC patients who have undergone R0 resection.
Chemoradiotherapy, Adjuvant ; Chemotherapy, Adjuvant ; Gallbladder Neoplasms* ; Gallbladder* ; Humans ; Propensity Score